CRI logo

Creotech Instruments (CRI)

Share price (7-session average)
828.33 PLN+10.12% w/w
Market cap
PLN 1.3B
52-week range
343.50 – 1,086.00 PLN

Prices as of October 6, 2026, delayed.

Last updated: Source: ESEF / ESPI / GPW

Compiled by: Zespół redakcyjny WszystkieAkcje.pl · Market data teamMethodology

Price Chart

Chart byTradingView

About Creotech Instruments

Creotech Instruments is a space company developing HyperSat microsatellite technology. The company designs and manufactures systems for the space industry and quantum computers.

This description was generated with the help of AI and may contain inaccuracies. Please verify important information from official sources.

Company Details

Company Name
CREOTECH INSTRUMENTS SPÓŁKA AKCYJNA
Ticker
CRI
ISIN
PLCRTCH00017
Listed Since
October 1, 2021
Shares Issued
2.85M
CEO
Grzegorz Brona
FIGI
BBG0131NNH70
Registered AddressUL. JANA PAWŁA II 66 05-500 PIASECZNO

Data sourced from GPW and OpenFIGI. Updated periodically — verify with official sources.

News

No news for CRI.

Communities

Creotech Instruments short interest

Disclosed net short positions in Creotech Instruments per the KNF register: 0.52% of share capital in total (1 holders). KNF discloses positions from 0.5%.

Position holderNet positionPreviousPosition date
QUBE RESEARCH & TECHNOLOGIES LIMITED0.52%—Sep 18, 2026

All GPW short positions →

Frequently asked questions

How much does a Creotech Instruments share cost?
The 7-day average share price of Creotech Instruments (CRI) on GPW is 828.33 PLN.
On which exchange is Creotech Instruments listed?
Creotech Instruments is listed on GPW under the ticker CRI, ISIN: PLCRTCH00017.
Is Creotech Instruments stock being shorted?
Yes — per the KNF short-selling register (as of October 6, 2026), 1 holder has disclosed net short positions in Creotech Instruments, totalling 0.52% of share capital. KNF discloses positions from 0.5%.

Similar companies — Nowe technologie

Explore the market

This information is provided for informational purposes only and does not constitute investment advice or a recommendation. Listings describe companies by the stated criteria and are not an inducement to buy or sell any financial instrument. Verify figures against official sources before making any investment decision.

Methodology & data sources